Celldex Therapeutics, Inc.
Anti-ALK antibodies and methods for use thereof

Last updated:

Abstract:

Provided herein are compositions, methods and uses involving antibodies that specifically bind to ALK, a receptor tyrosine kinase, and modulate the expression and/or activity of ALK. Also provided are uses and methods for treating, e.g., managing, disorders, such as cancer.

Status:
Grant
Type:

Utility

Filling date:

26 Aug 2016

Issue date:

17 Aug 2021